Integrating the Tumor Microenvironment into Cancer Therapy.

dc.contributor.authorSanegre, Sabina
dc.contributor.authorLucantoni, Federico
dc.contributor.authorBurgos-Panadero, Rebeca
dc.contributor.authorde La Cruz-Merino, Luis
dc.contributor.authorNoguera, Rosa
dc.contributor.authorÁlvaro Naranjo, Tomás
dc.date.accessioned2025-01-07T16:14:20Z
dc.date.available2025-01-07T16:14:20Z
dc.date.issued2020-06-24
dc.description.abstractTumor progression is mediated by reciprocal interaction between tumor cells and their surrounding tumor microenvironment (TME), which among other factors encompasses the extracellular milieu, immune cells, fibroblasts, and the vascular system. However, the complexity of cancer goes beyond the local interaction of tumor cells with their microenvironment. We are on the path to understanding cancer from a systemic viewpoint where the host macroenvironment also plays a crucial role in determining tumor progression. Indeed, growing evidence is emerging on the impact of the gut microbiota, metabolism, biomechanics, and the neuroimmunological axis on cancer. Thus, external factors capable of influencing the entire body system, such as emotional stress, surgery, or psychosocial factors, must be taken into consideration for enhanced management and treatment of cancer patients. In this article, we review prognostic and predictive biomarkers, as well as their potential evaluation and quantitative analysis. Our overarching aim is to open up new fields of study and intervention possibilities, within the framework of an integral vision of cancer as a functional tissue with the capacity to respond to different non-cytotoxic factors, hormonal, immunological, and mechanical forces, and others inducing stroma and tumor reprogramming.
dc.identifier.doi10.3390/cancers12061677
dc.identifier.issn2072-6694
dc.identifier.pmcPMC7352326
dc.identifier.pmid32599891
dc.identifier.pubmedURLhttps://pmc.ncbi.nlm.nih.gov/articles/PMC7352326/pdf
dc.identifier.unpaywallURLhttps://www.mdpi.com/2072-6694/12/6/1677/pdf?version=1593003821
dc.identifier.urihttps://hdl.handle.net/10668/27702
dc.issue.number6
dc.journal.titleCancers
dc.journal.titleabbreviationCancers (Basel)
dc.language.isoen
dc.organizationSAS - Hospital Universitario Virgen Macarena
dc.organizationSAS - Hospital Universitario Virgen Macarena
dc.pubmedtypeJournal Article
dc.pubmedtypeReview
dc.rightsAttribution 4.0 International
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectbiomarker discovery
dc.subjectimmune therapy
dc.subjectmechanotransduction
dc.subjectmetabolism
dc.subjectmetformin
dc.subjectmicrobiota
dc.subjectmitochondria
dc.subjectprognostic tools
dc.subjectstromal reprogramming
dc.subjectvitamin D3
dc.titleIntegrating the Tumor Microenvironment into Cancer Therapy.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number12

Files

Original bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
PMC7352326.pdf
Size:
6.63 MB
Format:
Adobe Portable Document Format